紫金礦業(02899.HK)擬38.83億元收購西藏巨龍銅業50.1%股權
格隆匯6月8日丨紫金礦業(02899.HK)發佈公告,為進一步增加公司資源儲備,提升境內超大型銅礦的供應能力,實現公司可持續發展,公司通過全資子公司西藏紫金擬以現金方式收購藏格集團、藏格控股、中勝礦業、深圳臣方、匯百弘實業持有的巨龍銅業合計50.1%股權,本次交易對價合計為人民幣38.8275億元。當驅龍銅多金屬礦(含榮木錯拉銅多金屬礦)二期新增15萬噸/日採選工程達到協議約定條件時,收購方將給予本次出售巨龍銅業股權的股東一定補償。
本次交易不構成關聯交易,亦不構成重大資產重組。本次交易經公司董事會審議通過。本次交易在公司董事會的投資決策範圍內,無須提請股東大會批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.